ONCE-DAILY ROCKLATAN (NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005%
Dead / Abandoned — Abandoned — no statement of use filed (as of 14 Mar 2022)
What this means for you
This application is over — abandoned 14 Mar 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88362781
- Mark type
- Design + words
- Filed
- 29 Mar 2019
- Published for opposition
- 11 Jun 2019
- Abandoned
- 14 Mar 2022
- Attorney of record
- Melissa W. Woo-Allen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of glaucoma and ocular hypertension
Owner
- Aerie Pharmaceuticals, Inc., Bedminster, NJ, US
- Aerie Pharmaceuticals, Inc., Bedminster, NJ, US
Prosecution history
- 14 Mar 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 14 Mar 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 10 Aug 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Aug 2021 — SOU EXTENSION 4 GRANTED
- 06 Aug 2021 — SOU EXTENSION 4 FILED
- 06 Aug 2021 — SOU TEAS EXTENSION RECEIVED
- 14 Jan 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Jan 2021 — SOU EXTENSION 3 GRANTED
- 12 Jan 2021 — SOU EXTENSION 3 FILED
- 12 Jan 2021 — SOU TEAS EXTENSION RECEIVED
- 07 Aug 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Aug 2020 — SOU EXTENSION 2 GRANTED
- 05 Aug 2020 — SOU EXTENSION 2 FILED
- 05 Aug 2020 — SOU TEAS EXTENSION RECEIVED
- 08 Apr 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED